Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2

Biochemistry

Volumn 49, Issue 8, 2010, Pages 1649-1657

  Flagler, Michael J ^a   Mahajan, Sujit S ^b   Kulkarni, Ashish A ^b   Iyer, Suri S ^b   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL PLATFORM; GLOBOTRIAOSYLCERAMIDE; GLYCAN STRUCTURES; GLYCANS; IN-VITRO; RECEPTOR BINDING; SHIGA TOXIN; STREPTAVIDIN;

AMINO ACIDS; BINDING ENERGY; BIOCHEMISTRY; ORGANIC ACIDS; PHOSPHATASES; PROTEINS; SURFACE PLASMON RESONANCE;

BINDING SITES;

AMINO ACID; ASPARAGINE; N ACETYLGALACTOSAMINE; PROTEIN SUBUNIT; STREPTAVIDIN; TRISACCHARIDE; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR BINDING; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID; SHIGA TOXIN 1; SHIGA TOXIN 2; SURFACE PLASMON RESONANCE; TRIHEXOSYLCERAMIDES; TRISACCHARIDES;

EID: 77749252762     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi902084y     Document Type: Article

References (50)

1. Siegler, R. L. (1995) The hemolytic uremic syndrome. Pediatr. Clin. North. Am. 42, 1505-1529.
2. (2005) Centers for Disease Control and Prevention Disease Listing, Enterohemorrhagic E. coli
3. Wong, C.S., Jelacic, S., Habeeb, R. L., Watkins, S. L., and Tarr, P. I. (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli 0157:H7 infections. N. Engl, J. Med. 342,1930-1936. (Pubitemid 30419087)
4. Donohue-Rolfe, A., Keusch, G. T., Edson, C., Thorley-Lawson, D., and Jacewicz, M. (1.984) Pathogenesis of Shigella diarrhea. IX. Simplified high, yield purification of Shigella toxin, and characterization of subunit composition and function by the use of subunitspecific monoclonal and polyclonal antibodies. J. Exp. Med. 160, 1767-1781.
5. Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T., and Igarashi, K. (1988) Site of action of a Vero toxin (VT2) from. Escherichia coli 0157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur- J- Biochem. 171, 45-50. (Pubitemid 18042873)
6. Donohue-Rolfe, A., Acheson, D. W., and Keusch, G. T. (1991) Shiga toxin: purification, structure, and function. Rey. Infect. Dis. 13 (Suppl. 4), S293-S297.
7. Tesh.V. L., and O'Brien, A. D. (1991) The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol. Microbiol. 5, 1817-1822.
8. Tesh, V. L., Burris, J. A., Owens, J. W., Gordon, V. M., Wadolkowski, E. A., O'Brien, A. D., and Samuel, J. E. (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61, 3392-3402.
9. Boerlin, P., McEwen, S. A., Boerlin-Petzold, F., Wilson, J. B., Johnson, R. P., and Gyles, C. L. (1999) Associations between, virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J.Clin. Microbiol. 37, 497-503. (Pubitemid 29091254)
10. Zheng, J., Cui, S., Teel, L.D., Zhao, S.,Singh, R.,O'Brien, A.D., and Meng, J. (2008) Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans. Appl. Environ. Microbiol. 74, 5645-5652.
11. Persson, S., Olsen, K. E., Ethelberg, S., and Scheutz, F. (2007) Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J. Clin. Microbiol. 45, 2020-2024. (Pubitemid 46933951)
12. Jacewicz, M., Clausen, H., Nudelman, E., Donohue-Rolfe, A., and Keusch, G. T. (1986) Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J. Exp. Med. 163, 1391-1404. (Pubitemid 16043460)
13. Jacewicz, M., Feldman, H. A., Donohue-Rolfe, A., Balasubramanian, K. A., and Keusch, G. T. (1989) Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J. Infect. Dis. 159, 881-889. (Pubitemid 19113074)
14. Jacewicz, M. S., Mobassaleh, M. Gross, S. K., Balasubramanian, K. A., Daniel, P. F., Raghavan, S., McCluer, R. H., and Keusch, G. T. (1994) Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J. Infect. Dis. 169, 538-546. (Pubitemid 24062995)
15. Lingwood, C. A., Law, H., Richardson, S., Petric, M., Brunton, J. L., De Grandis, S., and Karmali, M. (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J.Biol. Chem. 262, 8834-8839.
16. Lindberg, A. A., Brown, J. E., Stromberg, N., Westling-Ryd, M., Schultz, J. E., and Karlsson, K. A. (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262,1779-1785.
17. DeGrandis, S., Law, H., Brunton, J., Gyles, C., and Lingwood, C. A. (1989) Globotetraosylceramide is recognized by the pig edema disease toxin. J.Biol. Chem. 264, 12520-12525. (Pubitemid 19191144)
18. Friedrich, A. W., Bielaszewska, M., Zhang, W. L., Pulz, M., Kuczius, T., Ammon, A., and Karch, H. (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J.Infect. Dis. 185, 74-84. (Pubitemid 34043019)
19. Weinstein, D. L., Jackson, M. P., Samuel, J. E., Holmes, R. K., and O'Brien, A. D. (1988) Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. .7. Bacteriol. 170, 4223-4230.
20. Rutjes, N. W., Binnington, B. A., Smith, C. R., Maloney, M. D., and Lingwood, C. A. (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int. 62, 832-845.
21. Head, S. C., Karmali, M. A., and Lingwood, C. A. (1991)Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J. Biol. Chem. 206, 3617-3621.
22. Lingwood, C. A. (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4,147-153.
23. Weinstein, D. L., Jackson, M. P., Perera, L. P., Holmes, R. K., and O'Brien, A. D. (1989) In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity, Infect, Immun. 57, 3743-3750.
24. Takeda, T., Yoshino, K., Adachi, E., Sato, Y., and Yamagata, K. (1999) In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2. Microbiol. Immunol. 43, 331-337. (Pubitemid 29194202)
25. Nakajima, H., Kiyokawa, N., Katagiri, Y. U., Taguchi, T., Suzuki, T., Sekino, T., Mimori, K., Ebata, T., Saito, U., Nakao, H., Takeda, T., and Fujimoto, J. (2001) Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J. Biol. Chem. 276, 42915-42922. (Pubitemid 37370970)
26. Lundquist, J. J., and Toone, E. J. (2002) The cluster glycoside effect. Chem. Rev. 102, 555-578.
27. Lee, R. T., and Lee, Y. C. (2000) Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconfugate J. 17, 543-551.
28. St Hilaire, P. M., Boyd, M. K., and Toone, E. J. (1994) Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor. Biochemistry 33, 14452-14463.
29. Soltyk, A. M., MacKenzie, C. R., Wolski, V. M., Hirama, T., Kitov, P. L, Bundle, D. R., and Brunton, J. L. (2002) A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1.J. Biol. Chem. 277, 5351-5359. (Pubitemid 34968581)
30. Ling, H., Boodhoo, A., Hazes, B., Cummings, M. D., Armstrong, G. D., Brunton, J. L., and Read, R. J. (1998) Structure of the Shigalike toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37, 1777-1788. (Pubitemid 28099800)
31. Shimizu, H., Field, R. A., Homans, S. W., and Donohue-Rolfe, A. (1998) Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-I from Escherichia coli and the trisaccharide moiety of globotriaosylceramide. Biochemistry 37, 11078-11082. (Pubitemid 28368934)
32. Gamage, S. D., McGannon, C. M., and Weiss, A. A. (2004) Escherichia coll serogroup 0107/0117 lipopolysaccharide binds and neutralizes Shiga toxin 2. J. Bacteriol. 186, 5506-5512.
33. Kale, R. R., McGannon, C. M., Fuller-Schaefer, C., Hatch, D. M., Flagler, M. J., Gamage, S. D., Weiss, A. A., and Iyer, S. S. (2008)Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates, Angew. Chem., Int. Ed. Engl.
34. Hendrickson, W. A., Pahler, A., Smith, J. L., Satow, Y., Merritt, E. A., and Phizackerley, R. P. (1989) Crystal structure of core streptavidin determined from multiwavelength anomalous diffraction of synchrotron radiation, Proc. Natl. Acad. Sci. U.S.A. 86,2190-2194.
35. Hyre, D. E., Le Trong, L., Merritt, E. A., Eccleston, J. F., Green, N. M., Stenkamp, R. E., and Stayton, P. S. (2006) Cooperative hydrogen bond interactions in the streptavidin-biotin system. Protein Sci. 15,459-467. (Pubitemid 43306240)
36. Yang, N., Su, X., Tjong, V., and Knoll, W. (2007) Evaluation of twoand three-dimensional streptavidin binding platforms for surface plasmon resonance spectroscopy studies of DNA hybridization and protein-DNA binding. Biosens. Bioelectron. 22, 2700-2706. (Pubitemid 46484268)
37. Stenberg, E., Persson, B., Roos, H., and Urbaniczky, C. (1991) Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolaleled proteins. J. Colloid Interface Sci. 143, 513-526.
38. Kitova, E. N., Daneshfar, R., Marcato, P., Mulvey, G. L., Armstrong, G., and Klassen, J. S. (2005) Stability of the homopentameric B subunits of Shiga toxins 1 and 2 in solution and the gas phase as revealed by nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry. J. Am. Soc. Mass Spectrom. 16, 1957-1968. (Pubitemid 41642959)
39. Kitova, E. N., Mulvey, G. L., Dingle, T., Sinelnikov, L, Wee, S., Griener, T. P., Armstrong, G. D., and Klassen, J. S. (2009) Assembly and stability of the Shiga toxins investigated by electrospray ionization mass spectrometry. Biochemistry 48, 5365-5374.
40. O'Shannessy, D. J., and Winzor, D. J. (1996) Interpretation of deviations from pseudo-first-order kinetic behavior in the characterization of ligand binding by biosensor technology. Anal. Biochem. 236, 275-283.
41. Lewallen, D. M., Siler, D., and Iyer, S. S. (2009) Factors affecting protein-glycan specificity: effect of spacers and incubation time. Boiem BioChem 10, 1486-1489.
42. Rinaldi, S., Brennan, K. M., Goodyear, C. S., O'Leary, C., Schiavo, G., Crocker, P. R., and Willison, H. J. (2009) Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 19, 789-796.
43. Bast, D. J., Banerjee, L., Clark, C., Read, R. J., and Brunton, J. L. (1999) The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on. the verotoxin 1 B subunit. Mol. Microbiol. 32, 953-960. (Pubitemid 29255762)
44. Kitova, E. N., Kitov, P. L., Paszkiewicz, E., Kim, J., Mulvey, G. L., Armstrong, G. D., Bundle, D. R., and Klassen, J. S. (2007) Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry. Glycobiology 17, 1127-1137. (Pubitemid 47543406)
45. Ling, H., Boodhoo, A., Hazes, B., Cummings, M. D., Armstrong, G. D., Brunton, J. L., and Read, R. J. (1998) Structure of the Shigalike toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37, 1777-1788. (Pubitemid 28099800)
46. Thompson, G. S., Shimizu, H., Homans, S. W., and Donohue-Rolfe, A. (2000) Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements. Biochemistry 39, 13153-13156. (Pubitemid 30800995)
47. 47. Dohi, H., Nishida, Y., Mizuno M., Shinkai, M., Kobayashi, T., Takeda, T., Uzawa, H., and Kobayashi, K. (1999) Synthesis of an artificial glycoconjugate polymer carrying Pk-antigenic trisaccharide and its potent neutralization activity against Shiga-like toxin. Bioorg. Med. Chem. 7, 2053-2062. (Pubitemid 29457704)
48. 48. Kitov, P. L., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J., and Bundle, D. R. (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature.403, 669-672. (Pubitemid 30104009)
49. 49. Mulvey, G. L., Marcato, P., Kitov, P. L., Sadowska, J., Bundle, D. R., and Armstrong, G. D. (2003) Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J. Infect. Dis. 187, 640-649. (Pubitemid 36250028)
50. Kitov, P. I., Mulvey, G. L., Griener, T. P., Lipinski, T., Solomon, D., Paszkiewicz, E., Jacobson, J. M., Sadowska, J. M., Suzuki, M., Yamamura, K., Armstrong, G. D., and Bundle, D. R. (2008) In vivo supramolecular templating enhances the activity of multivalent ligands: a potential therapeutic against the Escherichia coli O157 AB5 toxins, Proc. Natl. Acad. Sci. U.S.A. 105, 16837-16842.